BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32760804)

  • 21. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
    Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
    Head Neck; 2016 Apr; 38(4):E76-80. PubMed ID: 26275126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images?
    Hwang I; Chong A; Jung SI; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K; Ryu SB
    Ann Nucl Med; 2013 Feb; 27(2):140-5. PubMed ID: 23076866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions.
    Capitanio S; Bongioanni F; Piccardo A; Campus C; Gonella R; Tixi L; Naseri M; Pennone M; Altrinetti V; Buschiazzo A; Bossert I; Fiz F; Bruno A; DeCensi A; Sambuceti G; Morbelli S
    World J Radiol; 2016 Feb; 8(2):200-9. PubMed ID: 26981229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas.
    Bertagna F; Treglia G; Piccardo A; Giubbini R
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3866-75. PubMed ID: 22904176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SMARCA4-deficient thoracic tumor detected by [
    Okazaki T; Yokoyama K; Tsuchiya J; Honda T; Ishikawa Y; Kirimura S; Miyazaki Y; Tateishi U
    Eur J Hybrid Imaging; 2021 Apr; 5(1):8. PubMed ID: 34181162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship Between Clinicopathological Characteristics and PET/CT Uptake in Esophageal Squamous Cell Carcinoma: [
    Dong Y; Wei Y; Chen G; Huang Y; Song P; Liu S; Zheng J; Cheng M; Yuan S
    Mol Imaging Biol; 2019 Feb; 21(1):175-182. PubMed ID: 29869060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidental focal uptake in colorectal location on oncologic ¹⁸FDG PET and PET/CT studies: histopathological findings and clinical significances.
    Fuertes J; Montagut C; Bullich S; Coma MI; Mestre-Fusco A; Suárez-Piñera M; Trampal C; Bellmunt J
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):95-101. PubMed ID: 25263718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological analysis and risk factors of advanced colorectal neoplasms incidentally detected by 18F-FDG PET-CT.
    Chung SM; Kim KO; Cho IH; Kim TN
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):407-413. PubMed ID: 27926665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
    Pennings JP; de Haas RJ; Murshid KJA; de Jong KP; Dierckx RAJO; Kwee TC
    Eur J Surg Oncol; 2019 Apr; 45(4):606-612. PubMed ID: 30594404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
    Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
    J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Liu C; Gong C; Liu S; Zhang Y; Zhang Y; Xu X; Yuan H; Wang B; Yang Z
    Oncologist; 2019 Dec; 24(12):e1277-e1285. PubMed ID: 31337657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography uptake in a giant adrenal myelolipoma.
    Ludwig V; Rice MH; Martin WH; Kelley MC; Delbeke D
    Mol Imaging Biol; 2002 Oct; 4(5):355-8. PubMed ID: 14537110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.
    Lee MS; Cho JY; Kim SY; Cheon GJ; Moon MH; Oh S; Lee J; Lee S; Woo S; Kim SH
    J Magn Reson Imaging; 2017 Feb; 45(2):597-609. PubMed ID: 27586519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer.
    Jadvar H; Henderson RW; Conti PS
    Mol Imaging Biol; 2006; 8(3):193-200. PubMed ID: 16565910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer.
    Rowe SP; Gage KL; Faraj SF; Macura KJ; Cornish TC; Gonzalez-Roibon N; Guner G; Munari E; Partin AW; Pavlovich CP; Han M; Carter HB; Bivalacqua TJ; Blackford A; Holt D; Dannals RF; Netto GJ; Lodge MA; Mease RC; Pomper MG; Cho SY
    J Nucl Med; 2015 Jul; 56(7):1003-1010. PubMed ID: 26069305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidental ¹⁸F-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies.
    Czepczyński R; Stangierski A; Oleksa R; Janicka-Jedyńska M; Czarnywojtek A; Ruchała M; Sowiński J
    Nucl Med Rev Cent East Eur; 2011; 14(2):68-72. PubMed ID: 22474717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.